We are in the process of launching our new website and appreciate your patience as we continue to make improvements.

Click here to go to the new homepage.

Dr. Michael Schneider appointed new CFO of NORMA Group

Maintal, Germany, 30 January 2015 – The Supervisory Board of NORMA Group SE (“NORMA Group”), a global market leader in engineered joining technology, has appointed Dr. Michael Schneider to be the company’s new Chief Financial Officer by September 2015 at the very latest. He will succeed Dr. Othmar Belker, who will leave NORMA Group by mutual agreement end of March 2015. Werner Deggim, CEO of NORMA Group, will attend to the tasks of the CFO during the transition phase.

Dr. Michael Schneider has many years of experience working in the areas of Finance and Controlling in the automotive, chemical and pharmaceutical industries. He joins NORMA Group from FTE automotive GmbH, a globally active supplier of hydraulic brake and clutch systems for the automotive industry. As its CFO, Dr. Schneider is responsible for all areas of Finance, but also Purchasing and IT. Previous to this position, he served as the CFO of the automotive industry supplier Veritas AG. Dr. Schneider began his professional career in 1988 with Hoechst AG (now Sanofi SA) and then joined Degussa AG (today EVONIK Industries AG) in 1993. From 1997 until 2000, he was responsible for the areas of Controlling and Accounting at Degussa Brasil in São Paulo. Dr. Schneider has a degree in business administration and received his PhD in the area of economic sciences from Justus Liebig University in Gießen.

I am pleased to see Dr. Schneider appointed CFO of NORMA Group and I am certain that he will carry on with NORMA Group’s successful strategy together with his fellow Board members. Dr. Schneider has a great deal of knowledge of finance and has gained in-depth industry experience both in Germany and abroad,” says Dr. Stefan Wolf, Chairman of the Supervisory Board of NORMA Group.

Dr. Othmar Belker took office as CFO in 2006 and was responsible for setting up the international finance department at NORMA Group. He also played a lead role in preparing the company’s IPO in 2011 and in the refinancing measures that followed. “I would like to expressly thank Dr. Belker for his contribution to the success of NORMA Group SE these last few years. He was instrumental in preparing the successful IPO and in organizing Group financing,” Dr. Wolf says.

Additional information on the company is available on www.normagroup.com. Please visit our platform www.normagroup.com/images to obtain press photos.

Dr. Michael Schneider appointed new CFO of NORMA Group.pdf

Questions?

Get in touch with us for more support.

Contact Us

To top